Pfizer Will Monitor Off-Label Drug Use And Report To IG Under Neurontin Settlement

Corporate integrity agreement will be carefully studied in pharmaceutical industry given uncertainties surrounding off-label promotion rules. Pfizer agrees to establish clear policies and keep close tabs on off-label use – but the agreement does not define prohibited or permitted activities.